Arcus Biosciences, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arcus Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Arcus Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$105M, a 31.3% decline year-over-year.
  • Arcus Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$318M, a 1.55% increase year-over-year.
  • Arcus Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$340M, a 21.4% decline from 2022.
  • Arcus Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$280M, a 619% decline from 2021.
  • Arcus Biosciences, Inc. annual Operating Income (Loss) for 2021 was $54M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$340M -$60M -21.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 -$280M -$334M -619% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $54M +$178M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$124M -$35.3M -39.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$88.7M -$33.9M -61.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$54.9M -$1.42M -2.65% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$53.4M -$35.3M -194% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-05
2016 -$18.2M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.